Sanaria

Sanaria

Sanaria is a biotechnology company developing vaccines protective against malaria and other infectious diseases as well as related products for use in malaria research. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Sanaria, United States, covering academic research published from 2002 to 2023. Read More.


Open Access Percentage

82%


Total
Publications

276


Total Open
Publications

226


Total
Citations

16K


Open Access
Percentage

82%


Total
Publications

276


Total Open
Publications

226


Total
Citations

16K

Wikipedia

Website

download

Breakdown

6% 63% 13% 18%

Publisher Open

6%

Both

63%

Other Platform Open

13%

Closed

18%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

051015202530Total Publications
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

54%OA Journal

OA Journal 54%

102

Hybrid 27%

51

No Guarantees 19%

36

Other Platform Open

Domain 83%

175

Institution 41%

86

Preprint 15%

31

Public 11%

23

Other Internet 10%

22

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
175
Europe PMC
Domain
109
Radboud University - Radboud Repository
Institution
30
University of Oxford - Oxford University Research Archive (ORA)
Institution
19
Semantic Scholar
Public
19
University of Basel - edoc
Institution
16
Research Square
Preprint
11
bioRxiv
Preprint
11
DOI
Other Internet
10
unl.edu OAI-PMH Repository
Institution
9
1 / 7

Data updated 13 August 2024

Share

Share

Share